Sign in
Stories
TheraVet's Successful Webinar on Canine Osteosarcoma
Share
TheraVet's VISCO-VET Patents
Overview
API
TheraVet, a pioneering biotechnology company, successfully organized an educational webinar on canine osteosarcoma in collaboration with Veterinary Instrumentation, garnering high participant positivity. Their product, BIOCERA-VET, is a line of biologically based bone substitutes for orthopedic surgery and palliative care of canine osteosarcoma, showing promising clinical results.
Ask a question
How might TheraVet's innovative approach to canine osteosarcoma impact the veterinary healthcare industry?
In what ways could TheraVet's success in this webinar influence the development of similar educational initiatives in the veterinary field?
What challenges or opportunities do TheraVet face in expanding the use of BIOCERA-VET for orthopedic surgery and palliative care in companion animals?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Coverage